Recornea is a pre-clinical stage medtech ophthalmic company developing therapeutic solutions for treating diseases of the cornea, such as keratoconus and corneal transplants. Keratoconus is a progressive eye disease causing distorted vision. Both current ocular surgeries and devices are not effective in reinstating a predictable, uniform and stable-in-time shape of the cornea leading to a very poor quality of vision and life for these patients. We develop the GROSSO® Implant, the first nitinol corneal implant to restore the physiological curvature of the cornea with clear and predictable clinical outcomes.